Loading data
IMAXNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 410.21 m USD | 352.21 m USD | 374.84 m USD | 300.81 m USD | 254.88 m USD |
| Cost of revenue | 164.02 m USD | 162.01 m USD | 160.5 m USD | 144.45 m USD | 120.48 m USD |
| Gross profit | 246.19 m USD | 190.2 m USD | 214.34 m USD | 156.36 m USD | 134.41 m USD |
| Research and development expense | 5.82 m USD | 5.1 m USD | 10.11 m USD | 5.3 m USD | 6.94 m USD |
| Selling, general and administrative expense | 138.46 m USD | 132.7 m USD | 144.41 m USD | 138.04 m USD | 117.32 m USD |
| Operating profit | 84.23 m USD | 43.86 m USD | 50.4 m USD | -4.83 m USD | 10.98 m USD |
| Interest expense | — | — | 6.82 m USD | 5.88 m USD | 7.09 m USD |
| Profit before tax | 63.29 m USD | 37.7 m USD | 46.12 m USD | -9.77 m USD | 10.99 m USD |
| Income tax expense | 17.77 m USD | 5 m USD | 13.05 m USD | 10.11 m USD | 20.56 m USD |
| Net income (reported basis) | 34.9 m USD | 26.1 m USD | 25.3 m USD | -22.8 m USD | -22.3 m USD |
| Basic earnings per share | 0.65 USD/share | 0.49 USD/share | 0.47 USD/share | -0.4 USD/share | -0.38 USD/share |
| Diluted earnings per share | 0.63 USD/share | 0.48 USD/share | 0.46 USD/share | -0.4 USD/share | -0.38 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.